SARTORIUS
Sartorius, a leading international partner of life science research and the biopharmaceutical industry, signed an agreement to acquire a majority stake in the Israeli cell culture media developer and manufacturer Biological Industries. For approximately €45 million in cash, Sartorius is acquiring just over 50% of the shares of the company from its owners, Kibbutz Beit Haemek and private equity fund Fortissimo Capital. An option to acquire a further 20% of the shares within three years was also agreed. The transaction is subject to customary closing conditions and expected to be finalized by mid-December.
“By acquiring a majority stake in Biological Industries, we are significantly expanding our cell culture media offering and complementing our product portfolio for customers in the dynamically growing advanced therapies market,” commented Joachim Kreuzburg, CEO of the Sartorius Group.
Biological Industries focuses on cell culture media, particularly for cell and gene therapy, regenerative medicine and other advanced therapies. Founded in 1981, the company currently employs approximately 130 people mainly at its headquarters, R&D and manufacturing site close to Haifa, Israel, and at sales locations in the USA, Europe and China. Biological Industries has recorded significant revenue growth and expects to achieve sales of approximately €25 million with a double-digit operating EBITDA margin in the current year.
Cell culture media are used in research, clinical development and production of biopharmaceuticals as well as in cell and tissue therapy applications. The company offers complete media solutions including a strong portfolio of clinical-grade media for cultivating cells and stem cells and for cryopreservation, applications that are both particularly relevant in advanced therapy research and clinical development. In addition, Biological Industries provides cell culture reagents as well as classical and serum-free media.
Follow Sartorius on Twitter @Sartorius_Group and on LinkedIn .
A profile of Sartorius
The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry. With innovative laboratory instruments and consumables, the Group’s Lab Products & Services Division concentrates on serving the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The Bioprocess Solutions Division with its broad product portfolio focusing on single-use solutions helps customers to manufacture biotech medications and vaccines safely and efficiently. The Group has a track record of double digit growth rates and has been regularly expanding its portfolio by acquisitions of complementary technologies. In fiscal 2018, Sartorius earned sales revenue of around 1.57 billion euros. Currently, more than 8,800 people work at the Group’s approximately 60 manufacturing and sales sites, serving customers around the globe.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191205005479/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Esri ArcGIS Location PlatformAdds Session Usage Pricing for Basemaps8.10.2025 20:44:00 CEST | Press release
New Model Offers Predictable, Flexible Cost Structure for High-Traffic and Long-Session Applications Esri, the global leader in location intelligence, today announced the release of a new session usage pricing model for basemaps available through ArcGIS Location Platform. This session usage model complements the existing tile usage pricing, which customers will still have the option to choose based on their operational needs. Developers and organizations will now have a more predictable and cost-effective way to integrate Esri’s high-quality basemaps into their applications and business systems. The additional pricing option for ArcGIS Location Platform is especially valuable for high-traffic applications or those with extended user sessions, such as real estate search portals, rideshare apps, or delivery tracking systems. By aligning pricing with actual user interactions—such as panning, zooming, and searching—developers can better forecast costs. “Organizations struggle with unpredic
Forum Invest in Senegal 2025 (Fii Senegal 2025): President Bassirou Diomaye Faye Calls for Investment in a Transforming Senegal8.10.2025 19:50:00 CEST | Press release
“Senegal offers a growing market within the framework of the Continental Free Trade Area, supported by a legal environment undergoing modernization and reform. We are ready to welcome you and facilitate your establishment and success. Come seize opportunities in high-potential strategic sectors and forge fruitful, mutually beneficial partnerships,” stated His Excellency President Bassirou Diomaye Faye at the opening of Forum Invest in Senegal 2025 (Fii Senegal 2025) (https://FiiSenegal.sn/). With these words, the Head of State set the tone for a forward-looking forum, symbolizing a Senegal firmly committed to the path of economic transformation, stability, and trust. The President reiterated the four pillars of Vision Senegal 2050—economic diversification, regional development, strengthened governance, and investment in human capital—as the guiding framework for the country’s long-term development. Following this, Bakary Séga Bathily, Director General of APIX, welcomed this direction,
Bacardi Legacy of Great Workplace Continues With Forbes Honor of “World’s Best Employers” in 20258.10.2025 17:25:00 CEST | Press release
Family-Owned Company Earns Top Rank Within Spirits Bacardi Limited is proud to once again land a spot on the Forbes’ list of the ‘World’s Best Employers 2025’ — proving that great people and a great culture never go out of style. The family-owned company is a repeat show on the global list which is based on more than 300,000 independent surveys conducted in more than 50 countries. Participants were asked whether they would recommend a company to family or friends, and to rate it based on such criteria as workplace environment, salary, and other key criteria. Bacardi, the world’s largest privately held international spirits company, earned the highest ranking of pure spirits companies coming in at #86. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251008919280/en/ Bacardi legacy of great workplace continues. “Being recognized again by Forbes among the World’s Top Employers is a true testament to our culture and the dedicatio
DevvStream Reports BTC and SOL Reserves as Crypto-Treasury Program Accelerates8.10.2025 17:00:00 CEST | Press release
DevvStream Corp. (Nasdaq: DEVS) (“DevvStream” or the “Company”), a leading carbon management firm specializing in the development, investment, and sale of environmental assets, today reported current holdings and progress under its crypto-treasury program, which is designed to add 24/7 liquidity and generate staking income. Portfolio snapshot (BitGo custody): Bitcoin ($BTC): approximately 22.229 BTC held, valued at (US) $2,716,162 as of October 7, 2025. Solana ($SOL): 12,110.98 SOL acquired year-to-date; 12,127.64 SOL staked, including rewards. Total SOL held is valued at (US) $2,718,489 as of October 7, 2025. USD balance: approximately (US) $1,280,000 in cash within BitGo. The Company has retained all digital-asset holdings accumulated under the program to date. The treasury is intended to create incremental income through SOL staking and establish on-chain readiness for tokenized real-world assets, including renewable-energy plants, energy-trading contracts, and other sustainability
Philip Morris International Urges U.S. Food and Drug Administration Advisory Committee to Recommend Continued Marketing of IQOS as Modified Risk Product8.10.2025 16:51:00 CEST | Press release
A pioneer in modified risk tobacco products, Philip Morris International is the only company to have received a modified risk marketing claim for an electronic nicotine device. FDA concludes “Evidence continues to support the modified exposure claim that ‘Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your body’s exposure to harmful or potentially harmful chemicals.’” Experts from Philip Morris International Inc. (NYSE: PM) presented evidence to the Tobacco Products Scientific Advisory Committee (TPSAC). The committee, comprised of independent scientific researchers, provides nonbinding recommendations to the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP). The full-day meeting on October 7 was part of the FDA’s customary review of PMI’s request to continue marketing versions of its IQOS heated tobacco products in the U.S. as modified risk tobacco products (MRTPs), a necessary ste
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom